The Right TraderBeta

Janux Therapeutics, Inc.

JANX
—
Advanced chart & tools →
Janux Therapeutics, Inc.JANX
$0.00
+$0.00(+NaN%)Past Year
$0.00$0.00$0.00$0.00
Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap
—
P/E ratio
—
EPS (diluted)
$-1.83
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$10.00M
Net income
$-113.63M
Net margin
-1136.3%
Gross margin
—

Dividends & financials

Janux Therapeutics, Inc. (JANX) reported revenue of $10.00M and net income of $-113.63M, or $-1.83 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.